Aclaris Therapeutics, Inc. - 8-K Filing
Aclaris Therapeutics held its annual stockholder meeting on June 4, 2026. Stockholders elected Anand Mehra and Maxine Gowen to the board with over 83 million votes each; approved executive compensation with 83.37 million votes in favor; and ratified PricewaterhouseCoopers as auditors with nearly all shares voting in favor. (Items: 5.07 Submission of Matters to a Vote of Security Holders)
Tickers: $ACRS